Takayuki Isagawa
Papers
1
Total Citations
1
H-Index
1
About
Dr. Takayuki Isagawa is a leading researcher in parasitology, with a specialized focus on protozoan parasites that pose significant threats to human and animal health. His work centers on the molecular biology and high-throughput screening of nucleoside triphosphate hydrolases (NTPases) in *Toxoplasma gondii* and *Neospora caninum*—two major apicomplexan parasites responsible for toxoplasmosis and neosporosis, respectively. Dr. Isagawa’s major contribution lies in developing an innovative, robot-arm-assisted assay for NTPase activity, enabling rapid, automated screening of potential inhibitors. This methodological advance is critical for identifying new therapeutics against these pathogens, which are particularly dangerous for immunocompromised individuals, including HIV-positive patients and organ transplant recipients, as well as pregnant women. His 2022 paper on this assay has garnered attention for its translational potential in drug discovery. By bridging parasitology and automation, Dr. Isagawa’s work accelerates the search for treatments against neglected parasitic diseases, demonstrating a profound impact on both basic science and clinical applications. His research continues to shape strategies for combating protozoan infections worldwide.
Research Focus
Key Achievements
Top Papers
- 1